Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

For profitWebsite ↗

Also known as: Hunan Kelun Pharmaceutical Co., Ltd. | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Sichuan Kelun Pharmaceutical Co., Ltd | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Sep 1, 2016

Last known activity

Feb 1, 2026

Timeline

1990s

Jan 1, 1998
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.— Founded

2010s

Oct 28, 2016
Klus Pharma Inc.— Acquired

Drugs by trial phase (46 distinct, 52 trials)

Phase 3 (14 own, 5 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (20 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Klus Pharma Inc.

Recent trials (50)

NCT07308106Lead sponsorPhase 2Feb 1, 2026
NCT07296809Lead sponsorPhase 2Dec 20, 2025
NCT07230405Lead sponsorPhase 2Dec 13, 2025
NCT07240675Lead sponsorPhase 1Nov 26, 2025
NCT07054242CollaboratorPhase 2Oct 30, 2025
NCT07179783CollaboratorPhase 2Sep 22, 2025
NCT07171034Lead sponsorPhase 1Sep 1, 2025
NCT07087197Lead sponsorPhase 1Aug 15, 2025
NCT07071337Lead sponsorPhase 3Jul 18, 2025
NCT07019675Lead sponsorPhase 2Jun 20, 2025
NCT07143318Lead sponsorPhase 1Jun 5, 2025
NCT07030790Lead sponsorPhase 1May 17, 2025
NCT06826040Lead sponsorPhase 1Feb 5, 2025
NCT06725381Lead sponsorPhase 1Dec 31, 2024
NCT06736327Lead sponsorPhase 1Dec 13, 2024

Details

Founded: Chengdu, CN Jan 1, 1998
Last known activity: Feb 1, 2026